Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer

被引:22
作者
Blazeby, JM [1 ]
Nicklin, J
Brookes, ST
Winstone, K
Alderson, D
机构
[1] Univ Bristol, Bristol Royal Infirm, Div Surg, Bristol BS2 8HW, Avon, England
[2] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
基金
英国医学研究理事会;
关键词
quality of life; EORTC QLQ-C30; compliance; upper gastrointestinal cancer;
D O I
10.1038/sj.bjc.6601146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Quality of life (QOL) is an important outcome after treatment for upper gastrointestinal tract cancer but few studies report good accrual and subsequent attrition is usually high. This study investigated the feasibility of a nurse-led service to obtain longitudinal QOL assessments and explored how clinical and sociodemographic factors influence patients' need for help to complete questionnaires. Fully informed patients were invited into the study. Baseline hospital assessments were scheduled by telephone and thereafter by post unless patients' health indicated the need for a home visit. In all, 128 out of 140 (91%) baseline QOL assessments were performed. Follow-up questionnaire completion was good, with 114 patients (89%) completing all but one of the expected assessments. At baseline, 41 (32%) patients required a lot of help to complete questionnaires. Patients requiring help were more likely to be undergoing palliative treatment than treatment aimed at cure (68 vs 33%; odds ratio 3.48, P<0.01). Patients' with advanced stage cancer of the upper gastrointestinal tract receiving palliative treatment require dedicated staff to ensure good compliance with longitudinal QOL data collection. It is essential to budget for this in clinical trails.
引用
收藏
页码:497 / 501
页数:5
相关论文
共 22 条
[11]   Outcome measures in palliative care for advanced cancer patients: A review [J].
Hearn, J ;
Higginson, IJ .
JOURNAL OF PUBLIC HEALTH MEDICINE, 1997, 19 (02) :193-199
[12]   Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer [J].
Ilson, DH ;
Saltz, L ;
Enzinger, P ;
Huang, Y ;
Kornblith, A ;
Gollub, M ;
O'Reilly, E ;
Schwartz, G ;
DeGroff, J ;
Gonzalez, G ;
Kelsen, DP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3270-3275
[13]   Practice and policy of measuring quality of life and health economics in cancer clinical trials: A survey among co-operative trial groups [J].
Kiebert, G ;
Wait, S ;
Bernhard, J ;
Bezjak, A ;
Cella, D ;
Day, R ;
Houghton, J ;
Moinpour, C ;
Scott, C ;
Stephens, R .
QUALITY OF LIFE RESEARCH, 2000, 9 (10) :1073-1080
[14]   The standard of reporting of health-related quality of life in clinical cancer trials [J].
Lee, CW ;
Chi, KN .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (05) :451-458
[15]   Alternative methods of interpreting quality of life data in advanced gastrointestinal cancer patients [J].
Nordin, K ;
Steel, J ;
Hoffman, K ;
Glimelius, B .
BRITISH JOURNAL OF CANCER, 2001, 85 (09) :1265-1272
[16]   Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PV1 5-FU) with epirubicin, cisplatin, and PV15-FU in advanced esophagogastric cancer [J].
Ross, P ;
Nicolson, M ;
Cunningham, D ;
Valle, J ;
Seymour, M ;
Harper, P ;
Price, T ;
Anderson, H ;
Iveson, T ;
Hickish, T ;
Lofts, F ;
Norman, A .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :1996-2004
[17]   Reporting on quality of life in randomised controlled trials: bibliographic study [J].
Sanders, C ;
Egger, M ;
Donovan, J ;
Tallon, D ;
Frankel, S .
BRITISH MEDICAL JOURNAL, 1998, 317 (7167) :1191-1194
[18]   Asking the obvious questions regarding patient burden [J].
Sloan, J .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :4-6
[19]   Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study [J].
Spencer, GM ;
Thorpe, SM ;
Blackman, GM ;
Solano, J ;
Tobias, JS ;
Lovat, LB ;
Bown, SG .
GUT, 2002, 50 (02) :224-227
[20]   Computer-based quality of life questionnaires may contribute to doctor-patient interactions in oncology [J].
Velikova, G ;
Brown, JM ;
Smith, AB ;
Selby, P .
BRITISH JOURNAL OF CANCER, 2002, 86 (01) :51-59